El-Bakly, Wesam M <br/><br/>
6-gingerol ameliorated doxorubicin-induced cardiotoxicity: role of nuclear factor kappa B and protein glycation.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  Dec 2012 
 - 833-41 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1432-0843 
<br/><br/><label>Standard No.: </label>10.1007/s00280-012-1975-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Animals<br/>Antibiotics, Antineoplastic--administration & dosage<br/>Caspase 3--metabolism<br/>Catechols--administration & dosage<br/>Creatine Kinase, MB Form--metabolism<br/>Doxorubicin--administration & dosage<br/>Fatty Alcohols--administration & dosage<br/>Heart--drug effects<br/>Heart Diseases--blood<br/>Immunohistochemistry<br/>Infusions, Parenteral<br/>Male<br/>Myocardium--metabolism<br/>NF-kappa B--metabolism<br/>Oxidative Stress<br/>Rats<br/>Rats, Inbred Strains<br/>Receptor for Advanced Glycation End Products<br/>Receptors, Immunologic--metabolism